Page last updated: 2024-10-25

cisapride and Cancer of Pancreas

cisapride has been researched along with Cancer of Pancreas in 1 studies

Cisapride: A substituted benzamide used for its prokinetic properties. It is used in the management of gastroesophageal reflux disease, functional dyspepsia, and other disorders associated with impaired gastrointestinal motility. (Martindale The Extra Pharmacopoeia, 31st ed)
cisapride : The amide resulting from formal condensation of 4-amino-5-chloro-2-methoxybenzoic acid with cis-1-[3-(4-fluorophenoxy)propyl]-3-methoxypiperidin-4-amine. It has been used (as its monohydrate or as its tartrate) for the treatment of gastro-oesophageal reflux disease and for non-ulcer dyspepsia, but its propensity to cause cardiac arrhythmias resulted in its complete withdrawal from many countries, including the U.K., and restrictions on its use elsewhere.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Lytras, D1
Paraskevas, KI1
Avgerinos, C1
Manes, C1
Touloumis, Z1
Paraskeva, KD1
Dervenis, C1

Reviews

1 review available for cisapride and Cancer of Pancreas

ArticleYear
Therapeutic strategies for the management of delayed gastric emptying after pancreatic resection.
    Langenbeck's archives of surgery, 2007, Volume: 392, Issue:1

    Topics: Cisapride; Enteral Nutrition; Gastric Emptying; Gastrointestinal Agents; Humans; Intubation, Gastroi

2007